Pharmacotherapy for obesity - Do the benefits outweigh the risks?

New England Journal of Medicine

Volumn 335, Issue 9, 1996, Pages 659-660

  Manson, J E ^a   Faich, G A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; DEXFENFLURAMINE;

BODY MASS; DISEASE ASSOCIATION; EDITORIAL; HUMAN; MORTALITY; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; UNITED STATES;

APPETITE DEPRESSANTS; FENFLURAMINE; HUMANS; HYPERTENSION, PULMONARY; OBESITY;

EID: 0029799509     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608293350910     Document Type: Editorial

References (0)